Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

By A. Dasari, Chan Shen, D. Halperin, Bo Zhao, Shouhao Zhou, Ying Xu, T. Shih, James C. Yao. JAMA Oncology, 2017

3,077 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology

View Paper: https://www.semanticscholar.org/paper/76bfb8fec0cbdfbc35930345d612b94ac4381727

Citations in the corpus

• Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2020, neutral): “The incidence of GEP-NENs has increased more than six-fold between 1997 and 2012 [1].”